李高峰.介入化疗联合放疗治疗65例原发性巨块型肝癌的临床观察.[J].中南医学科学杂志.,2013,41(2):151-153. |
介入化疗联合放疗治疗65例原发性巨块型肝癌的临床观察 |
Combined Therapy of Interventional Chemotherapy with Three-Dimentional Conformal Radiotherapy for the Treatment of Huge Liver Cancer |
投稿时间:2012-10-09 |
DOI: |
中文关键词: 介入化疗 放射治疗 原发性巨块型肝癌 |
英文关键词:interventional therapy three-dimenitonal conformal radiotherapy huge liver cancer |
基金项目:广西壮族自治区自然科学基金资助(10124001B-7) |
|
摘要点击次数: 865 |
全文下载次数: 1675 |
中文摘要: |
目的研究介入化疗联合放射治疗原发性巨块型肝癌的临床疗效及毒副作用。方法对65例患者先行介入化疗,随后行三维适形放疗。结果治疗后完全缓解15例,部分缓解35例,无变化7例,1、2、3 年存活率分别为82.2%、54.5%、30.3%。治疗后部分患者出现副作用,但经处理后均能完成治疗。结论介入化疗联合放疗能提高原发性巨块型肝癌的临床疗效,延长生存期,毒副作用可耐受。 |
英文摘要: |
ObjectiveTo evaluate the treatment efficency and side effects of interventional chemotherapy with three-dimenitonal conformal radiotherapy(3DCRT)for the treatment of huge liver cancer.Methods65 patients with huge liver cancer were treated with interventional therapy and 3DCRT.ResultsThe effective rate(CR+PR) was 76.9%,and the survival rate of 1,2,3 years were 82.2%,54.5%,30.3%.The main side effects and major toxicity of radiotherapy and chemotherapy were tolerated.ConclusionsIntervenitonal therapy with three-dimentional conformal radiotherapy can significantly raise the effective rate and survival rate. |
查看全文 查看/发表评论 下载PDF阅读器 |
关闭 |